Search

University of Alabama at Birmingham, USA is hiring a Researcher to investigate phage host range, genetic mobilization, and antibiotic resistance in staphylococci and streptococci, involving microbial genetics, biochemistry, and structural b

Wondering how phage therapy startups raise money? PhageLab recently raised $11M, and this ‘pitch deck teardown’ blog post goes through the pitch deck they used to convince investors, which slides pack the most punch, and other tips.

The International Society of Viruses of Microorganisms (ISVM) is calling for applications to organize the Viruses of Microbes (VoM) 2026 conference. Interested ISVM members should submit their applications by April 30, 2024, to board@isvm.

The 2nd Symposium of the Belgian Society for Viruses of Microbes (BSVoM) was held on September 8, 2023, at the University of Liège, featuring over 140 researchers from 10 countries discussing phage ecology, diversity, and applications. The

The BV-BRC Viral Sub-species Classification Workshop, funded by NIAID, will be held in Rockville, MD from April 8-10, 2024. This hybrid event, in collaboration with the CDC and NCBI, aims to establish best practices for viral sub-species c

Precisio Biotix Therapeutics has acquired London-based CC Bio. This gives Precisio access to CC Bio's ZEUS lysin platform, a bioinformatics platform highly complementary to Precisio's high-throughput screening, engineering, and AI system fo

PrecisionPhage, a new startup based in Finland, has launched Phagenomics, a browser-based tool for phage genome analysis to streamline assembly and annotation for researchers and clinicians.

Milan Gerovac (University of Würzburg) and colleagues published a new paper revealing how phage-encoded proteins, particularly from jumbo phage ΦKZ, target and co-opt P. aeruginosa ribosomes immediately after infection. They make the case t

The CDC has launched an Antimicrobial Resistance Investment Map (interestingly, they are calling it ‘AR’ now — is this our new acronym for AMR?). The map illustrates the allocation of CDC funds in the US and abroad. Explore funding landscap

The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is offering funding for Phase II or III clinical trials focusing on antimicrobial agents for multi-resistant Gram-negative bacilli infections. Application deadline

This week we're highlighting a brand new paper out of the Bordenstein lab, out yesterday in Science, that unravels the mechanism by which prophage-encoded proteins control whether Drosophila flies reproduce or not. This week things take a d

Little is known about the interactions between phages and bacteria in densely packed and spatially structured biofilm communities. The River Ecosystems Laboratory at EPFL, Switzerland is hiring a postdoc to study interactions between phages

FDA (Silver Spring, Maryland) is offering a postbac fellowship to develop and characterize phage therapy for decolonizing Vancomycin-resistant Enterococci, focusing on overcoming bacterial resistance.

In a recent podcast episode of This Week in Virology (TWiV), learn how a viral capsid protein activates a bacterial innate immune system, interfering with protein synthesis, and human-associated redondoviruses that infect the commensal prot

In another recent TWiV episode, learn how mammalian cells internalize and utilize phage particles to enhance cell growth and survival.

BiomX and Adaptive Phage Therapeutics have announced they will merge! They concurrently announce new financing of $50 million, which will help advance the combined company’s two Phase 2 assets: one for CF and one for diabetic foot ulcers.

Armata Pharmaceuticals has announced a $35 million credit agreement with its largest shareholder, Innoviva.

The UK government has responded to the Science, Innovation, and Technology Committee's report on the antimicrobial potential of phages, outlining recommendations for assessing the safety and effectiveness of phages in healthcare settings.

Owen Tuck and colleagues have discovered the Hachiman defense system, a broad-spectrum antiphage defense system, activates in response to DNA damage, creating 'phantom' cells devoid of both phage and host DNA. Preprint | Tweet thread

Attention phage researchers! The Felix d'Herelle Center is calling for deposits of characterized phages to ensure permanent archiving and prevent loss when research projects end. Have you considered depositing your lab's collection?